Lin‐Hai Yan
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 4
- Cancer-related gene regulation 2
- Epigenetics and DNA Methylation 2
- Oncology 6
- Co-authors
- Yubo Xie (7 shared papers)Weiyuan Wei (6 shared papers)Wenlong Cao (5 shared papers)Qiang Xiao (5 shared papers)Li Li (1 shared paper)Lu Lu (1 shared paper)Ying Li (1 shared paper)Xianwei Mo (5 shared papers)
- Journals
- Journal of Cancer (3 papers)OncoTargets and Therapy (2 papers)World Journal of Gastroenterology (2 papers)Chinese Journal of Cancer (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lin‐Hai Yan
22 papers receiving 313 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 122
- Molecular Biology 181
- Oncology 65
- Pathology and Forensic Medicine 26
- Cell Biology 19
Countries citing papers authored by Lin‐Hai Yan
This map shows the geographic impact of Lin‐Hai Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Hai Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Hai Yan more than expected).
Fields of papers citing papers by Lin‐Hai Yan
This network shows the impact of papers produced by Lin‐Hai Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Hai Yan. The network helps show where Lin‐Hai Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin‐Hai Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 47 | |
| 2 | 2014 | 41 | |
| 3 | 2016 | 28 | |
| 4 | 2013 | 25 | |
| 5 | Targeting snoRNAs as an emerging method of therapeutic development for cancer. | 2019 | 22 |
| 6 | 2019 | 21 | |
| 7 | Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance. | 2015 | 21 |
| 8 | MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy. | 2015 | 20 |
| 9 | 2016 | 15 | |
| 10 | 2013 | 14 | |
| 11 | 2023 | 12 | |
| 12 | 2014 | 9 | |
| 13 | 2018 | 9 | |
| 14 | OX40 as a novel target for the reversal of immune escape in colorectal cancer. | 2021 | 9 |
| 15 | 2021 | 7 | |
| 16 | 2025 | 5 | |
| 17 | Consumptive hypothyroidism due to a gastrointestinal stromal tumor expressing type 3 iodothyronine deiodinase. | 2015 | 4 |
| 18 | 2022 | 3 | |
| 19 | 2009 | 3 | |
| 20 | 2018 | 2 |
About Lin‐Hai Yan
Lin‐Hai Yan is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Immunology, having authored 23 papers that have together received 319 indexed citations. Recurring topics across this work include Digestive system and related health (4 papers), RNA modifications and cancer (4 papers), Immunotherapy and Immune Responses (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer-related gene regulation (2 papers), Immune Cell Function and Interaction (2 papers), Epigenetics and DNA Methylation (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (122 citations), Molecular Biology (181 citations), Oncology (65 citations), Pathology and Forensic Medicine (26 citations) and Cell Biology (19 citations). Lin‐Hai Yan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yubo Xie, Weiyuan Wei, Wenlong Cao, Qiang Xiao, Li Li, Lu Lu, Ying Li, Xianwei Mo, Jiansi Chen and Xiaoshi Zhang. Their work appears in journals such as Journal of Cancer, OncoTargets and Therapy, World Journal of Gastroenterology, Chinese Journal of Cancer and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.